[1]    C.A. Nickerson,  and et al., "Microbial responses to microgravity and other low-shear environments." Microbiology and Molecular Biology Reviews, vol. 68, no. 2, p. 345-361, 2004.

[2]    J. Huangfu,  and et al., "Omics analysis reveals the mechanism of enhanced recombinant protein production under simulated microgravity." Frontiers in bioengineering and biotechnology, vol. 8, p. 30, 2020.

[3]    P.R. Murray, and K.S. Rosenthal, Review of medical microbiology, Elsevier Health Sciences. 2005.

[4]    M. Rojas-Lopez, and et al., "Intestinal pathogenic Escherichia coli: Insights for vaccine development." Frontiers in microbiology, vol. 9, p. 440, 2018.

[5]    N. Engedal, and et al., "Shiga toxin and its use in targeted cancer therapy and imaging." Microbial biotechnology, vol. 4, no. 1, p. 32-46, 2011.

[6]    D.R. Sizemore, K.L. Roland, and U.S. Ryan, "Enterotoxigenic Escherichia coli virulence factors and vaccine approaches." Expert review of vaccines, vol. 3, no. 5, p. 585-595, 2004.

[7]    J. Sánchez, and J. Holmgren, "Virulence factors, pathogenesis and vaccine protection in cholera and ETEC diarrhea." Current opinion in immunology, vol. 17, no. 4, pp. 388-398, 2005.

[8]    P. Saeedi, and et al., "Advances and challenges in recombinant protein expression in Escherichia coli." New Cellular and Molecular Biotechnology Journal, vol. 9, no. 36, pp. 9-42, 2019.

[9]    B. Huang, and et al., "Effects of spaceflight and simulated microgravity on microbial growth and secondary metabolism." Military Medical Research,. vol. 5, no. 1, pp. 1-14, 2018.

[10]  Y. Huang, and et al., "Enhanced S‐adenosyl‐l‐methionine production in Saccharomyces cerevisiae by spaceflight culture, overexpressing methionine adenosyltransferase and optimizing cultivation." Journal of applied microbiology, vol. 112, no. 4, pp. 683-694, 2012.

[11]  L. Xiang, and et al., "Simulated microgravity affects growth of Escherichia coli and recombinant β-D-glucuronidase production." Applied biochemistry and biotechnology, vol. 162, no. 3, p. 654-661, 2010.

[12]  F. Qi, and et al., "Enhancement of recombinant β‐D‐glucuronidase production under low‐shear modeled microgravity in Pichia pastoris." Journal of Chemical Technology & Biotechnology, 2011. vol. 86, no. 4, 2011, pp. 505-511.

[13]  J. Huangfu, and et al., "Novel helper factors influencing recombinant protein production in Pichia pastoris based on proteomic analysis under simulated microgravity." Applied microbiology and biotechnology, vol. 99, no. 2, pp. 653-665, 2015.

[14]  S. Navran, Rotary bioreactor for recombinant protein production, in Cell Technology for Cell Products, Springer, pp. 567-569, 2007.

[15]  M.A. Saarinen, and D.W. Murhammer, "Culture in the rotating-wall vessel affects recombinant protein production capability of two insect cell lines in different manners." In Vitro Cellular & Developmental Biology-Animal, vol. 36, no. 6, pp. 362-366, 2000.

[16]  R., G Willaert, "The growth behavior of the model eukaryotic yeast Saccharomyces cerevisiae in microgravity." Current Biotechnology, vol. 2, no. 3, pp. 226-234, 2013.

[17]  G. Senatore, and et al., "Effect of microgravity & space radiation on microbes." Future microbiology, vol. 13, no. 07, pp. 831-847, 2018.

[18] Z. Gitai, and L. Shapiro, "Bacterial cell division spirals into control." Proceedings of the National Academy of Sciences. vol. 100, no. 13, pp. 7423-7424, 2003.

[19]  United Nations., Teacher’s Guide to Plant Experiments in Microgravity. Human Space Technology Initiative, 2013.

1996. Bollag, D. Michael, and J. Stuart, Protein methods, 2nd Ed. A John Willey and Sons. Inc. Pub., New York, 1996.

[21]  P.T. Wingfield, I. Palmer, and S.M. "Liang, Folding and purification of insoluble (inclusion body) proteins from Escherichia coli." Current protocols in protein science, vol. 1, p. 6.5,1995.

[22]  D.W. Carr, and J.D. Scott, Blotting and band-shifting: techniques for studying protein-protein interactions. Trends in biochemical sciences,. vol. 17, no. 7, pp. 246-249, 1992.

[23]  T. San-Miguel, P. Pérez-Bermúdez, and I. Gavidia, Production of soluble eukaryotic recombinant proteins in E. coli is favoured in early log-phase cultures induced at low temperature. Springerplus, vol. 2, no. 1, pp. 1-4, 2013.

[24]  R.G. Harrison, and M.J. Bagajewicz, "Predicting the solubility of recombinant proteins in Escherichia coli." Insoluble Proteins, p. 403-408, 2015.

[25]  V.A. Garcia-Angulo, A. Kalita, and A.G. Torres, "Advances in the development of enterohemorrhagic Escherichia coli vaccines using murine models of infection." Vaccine, vol. 31, no. 32, pp. 3229-3235, 2013.

[26]  M.P. Stevens and et al., "Options for the control of enterohaemorrhagic Escherichia coli in ruminants." Microbiology, vol. 148, no. 12, pp. 3767-3778, 2002.

[27]  R. Kazemi, and et al., "Cloning and expression of the binding subunit of shiga-like toxin type 2 gene and immunization study in an animal model." Pathobiology Research, vol.18, no. 4, p. 45-60. 2016

[28]  Nelson, D., Lehninger principles of biochemistry Macmillan,  Lehninger principles of biochemistry: Macmillan, 2008.

[29]  B. Muntari, and et al., "Recombinant bromelain production in Escherichia coli: process optimization in shake flask culture by response surface methodology." AMB express, vol. 2, no. 1, p.p. 1-9, 2012.